Aequus Granted European Patent for Once-Weekly Transdermal Aripiprazole
VANCOUVER, BC--(Marketwired - November 16, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting …